SEC Filing Alert: Knight Jeff E. (0001881007) Reports Activity
In a recent SEC filing, Knight Jeff E. (0001881007) disclosed important information that investors and stakeholders should take note of....
Month: June 2024
Holdco Nuvo Group D.G Ltd. (0001990145) Submits F-1 Form to SEC
In a recent SEC filing, Holdco Nuvo Group D.G Ltd. submitted Form F-1. This filing is significant as it indicates...
Calamos ETF Trust Files Form 497 with SEC
Calamos ETF Trust, represented by the filer with CIK number 0001579881, has submitted a Form 497 to the Securities and...
PAR Investment Partners LP Files SC 13G/A Form with SEC
**PAR Investment Partners LP Files SC 13G/A Form with the SEC** PAR Investment Partners LP, a well-known investment firm, has...
Trivago N.V. (0001683825) Subject of SC 13G/A Filing: What Investors Need to Know
In a recent SEC filing, Trivago N.V. (0001683825) submitted a SC 13G/A form, indicating a significant event impacting the company's...
Bank of America Corp Files 424B2 Form with SEC
Bank of America Corp/DE recently filed a 424B2 form with the Securities and Exchange Commission, indicating a significant event or...
BofA Finance LLC (0001682472) Submits 424B2 Form to SEC
BofA Finance LLC, a financial entity with the SEC CIK number 0001682472, has submitted a 424B2 form to the Securities...
Bank of Nova Scotia (0000009631) Files FWP – Learn More About the Latest Subject
The recent FWP (free writing prospectus) filed by the Bank of Nova Scotia (CIK: 0000009631) holds significant importance for investors...
Jerash Holdings (US), Inc. Files 10-K Form with SEC
Jerash Holdings (US), Inc. recently submitted its annual report on Form 10-K to the Securities and Exchange Commission (SEC). The...
Bank of Montreal Files Form FWP with the SEC Regarding (Subject)
In a recent filing with the Securities and Exchange Commission, the Bank of Montreal /CAN/ (CIK: 0000927971) submitted a Free...
Kiniksa Pharmaceuticals International, plc Submits Form 15-15D to SEC
Kiniksa Pharmaceuticals International, plc recently filed a Form 15-15D with the Securities and Exchange Commission (SEC), signaling its intent to...
Kiniksa Pharmaceuticals International, plc Files S-3 Form with SEC
Kiniksa Pharmaceuticals International, plc recently filed a Form S-3 with the Securities and Exchange Commission, indicating its intention to offer...